Justin S Golub1, Adam M Brickman2, Adam J Ciarleglio3, Nicole Schupf2,4, José A Luchsinger4,5. 1. Department of Otolaryngology-Head and Neck Surgery, Vagelos College of Physicians and Surgeons, New York-Presbyterian/Columbia University Irving Medical Center, Columbia University, New York. 2. Department of Neurology, Taub Institute for Research in Alzheimer's Disease and the Aging Brain, and Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, New York-Presbyterian/Columbia University Irving Medical Center, Columbia University, New York. 3. Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, DC. 4. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. 5. Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian/Columbia University Irving Medical Center, Columbia University, New York.
Abstract
Importance: Age-related hearing loss (HL) is a common and treatable condition that has been associated with cognitive impairment. The level of hearing at which this association begins has not been studied to date. Objective: To investigate whether the association between hearing and cognition is present among individuals traditionally classified as having normal hearing. Design, Setting, and Participants: Cross-sectional study of 2 US epidemiologic studies (Hispanic Community Health Study [HCHS], 2008-2011, and National Health and Nutrition Examination Study [NHANES], 1999-2000, 2001-2002, and 2011-2012 cycles). The dates of analysis were November 2018 to August 2019. Multivariable generalized additive model (GAM) regression and linear regression were used to assess the association between HL (exposure) and cognition (outcome). Participants included 6451 individuals aged 50 years or older from the general Hispanic population (HCHS [n = 5190]) and the general civilian, noninstitutionalized US population (NHANES [n = 1261]). Exposures: Audiometric HL (4-frequency pure-tone average). Main Outcomes and Measures: Neurocognitive performance measured by the Digit Symbol Substitution Test (DSST) (score range, 0-113), Word Frequency Test (range, 0-49), Spanish-English Verbal Learning Test (SEVLT) 3 trials (range, 5-40), SEVLT recall (range, 0-15), and Six-Item Screener (range, 0-6); higher scores indicated better cognitive performance. Results: Among 6451 individuals, the mean (SD) age was 59.4 (6.1) years, and 3841 (59.5%) were women. The GAM regression showed a significant inverse association between hearing and cognition across the entire spectrum of hearing after adjusting for demographics and cardiovascular disease. In separate multivariable linear regressions stratified by the classic binary definition of HL, decreased hearing was independently associated with decreased cognition in adults with normal hearing (pure-tone average ≤25 dB) across all cognitive tests in the HCHS. For example in this group, a 10-dB decrease in hearing was associated with a clinically meaningful 1.97-point (95% CI, 1.18-2.75) decrease in score on the DSST. When using a stricter HL cut point (15 dB), an association was also present in NHANES. The associations between hearing and cognition were stronger or equivalent in individuals with normal hearing than among those with HL. For example, there was a 2.28-point (95% CI, 1.56-3.00) combined cohort DSST score decrease per 10-dB decrease among individuals with normal hearing vs a 0.97-point (95% CI, 0.20-1.75) decrease among those with HL, with a significant interaction term between continuous and binary hearing. Conclusions and Relevance: An independent association was observed between cognition and subclinical HL. The association between hearing and cognition may be present earlier in HL than previously understood. Studies investigating whether treating HL can prevent impaired cognition and dementia should consider a lower threshold for defining HL than the current 25-dB threshold.
Importance: Age-related hearing loss (HL) is a common and treatable condition that has been associated with cognitive impairment. The level of hearing at which this association begins has not been studied to date. Objective: To investigate whether the association between hearing and cognition is present among individuals traditionally classified as having normal hearing. Design, Setting, and Participants: Cross-sectional study of 2 US epidemiologic studies (Hispanic Community Health Study [HCHS], 2008-2011, and National Health and Nutrition Examination Study [NHANES], 1999-2000, 2001-2002, and 2011-2012 cycles). The dates of analysis were November 2018 to August 2019. Multivariable generalized additive model (GAM) regression and linear regression were used to assess the association between HL (exposure) and cognition (outcome). Participants included 6451 individuals aged 50 years or older from the general Hispanic population (HCHS [n = 5190]) and the general civilian, noninstitutionalized US population (NHANES [n = 1261]). Exposures: Audiometric HL (4-frequency pure-tone average). Main Outcomes and Measures: Neurocognitive performance measured by the Digit Symbol Substitution Test (DSST) (score range, 0-113), Word Frequency Test (range, 0-49), Spanish-English Verbal Learning Test (SEVLT) 3 trials (range, 5-40), SEVLT recall (range, 0-15), and Six-Item Screener (range, 0-6); higher scores indicated better cognitive performance. Results: Among 6451 individuals, the mean (SD) age was 59.4 (6.1) years, and 3841 (59.5%) were women. The GAM regression showed a significant inverse association between hearing and cognition across the entire spectrum of hearing after adjusting for demographics and cardiovascular disease. In separate multivariable linear regressions stratified by the classic binary definition of HL, decreased hearing was independently associated with decreased cognition in adults with normal hearing (pure-tone average ≤25 dB) across all cognitive tests in the HCHS. For example in this group, a 10-dB decrease in hearing was associated with a clinically meaningful 1.97-point (95% CI, 1.18-2.75) decrease in score on the DSST. When using a stricter HL cut point (15 dB), an association was also present in NHANES. The associations between hearing and cognition were stronger or equivalent in individuals with normal hearing than among those with HL. For example, there was a 2.28-point (95% CI, 1.56-3.00) combined cohort DSST score decrease per 10-dB decrease among individuals with normal hearing vs a 0.97-point (95% CI, 0.20-1.75) decrease among those with HL, with a significant interaction term between continuous and binary hearing. Conclusions and Relevance: An independent association was observed between cognition and subclinical HL. The association between hearing and cognition may be present earlier in HL than previously understood. Studies investigating whether treating HL can prevent impaired cognition and dementia should consider a lower threshold for defining HL than the current 25-dB threshold.
Authors: Nicole M Armstrong; Yang An; Luigi Ferrucci; Jennifer A Deal; Frank R Lin; Susan M Resnick Journal: J Gerontol A Biol Sci Med Sci Date: 2020-02-14 Impact factor: 6.053
Authors: Jennifer A Deal; A Richey Sharrett; Marilyn S Albert; Josef Coresh; Thomas H Mosley; David Knopman; Lisa M Wruck; Frank R Lin Journal: Am J Epidemiol Date: 2015-04-04 Impact factor: 4.897
Authors: Frank R Lin; Luigi Ferrucci; E Jeffrey Metter; Yang An; Alan B Zonderman; Susan M Resnick Journal: Neuropsychology Date: 2011-11 Impact factor: 3.295
Authors: David G Loughrey; Michelle E Kelly; George A Kelley; Sabina Brennan; Brian A Lawlor Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-02-01 Impact factor: 6.223
Authors: Jacobijn Gussekloo; Anton J M de Craen; Charlène Oduber; Martin P J van Boxtel; Rudi G J Westendorp Journal: Am J Geriatr Psychiatry Date: 2005-09 Impact factor: 4.105
Authors: Frank R Lin; Kristine Yaffe; Jin Xia; Qian-Li Xue; Tamara B Harris; Elizabeth Purchase-Helzner; Suzanne Satterfield; Hilsa N Ayonayon; Luigi Ferrucci; Eleanor M Simonsick Journal: JAMA Intern Med Date: 2013-02-25 Impact factor: 21.873
Authors: Jennifer A Deal; Josh Betz; Kristine Yaffe; Tamara Harris; Elizabeth Purchase-Helzner; Suzanne Satterfield; Sheila Pratt; Nandini Govil; Eleanor M Simonsick; Frank R Lin Journal: J Gerontol A Biol Sci Med Sci Date: 2017-05-01 Impact factor: 6.053
Authors: Alexandria L Irace; Nicole M Armstrong; Jennifer A Deal; Alexander Chern; Luigi Ferrucci; Frank R Lin; Susan M Resnick; Justin S Golub Journal: J Gerontol A Biol Sci Med Sci Date: 2022-03-03 Impact factor: 6.591
Authors: Justin S Golub; Katharine K Brewster; Adam M Brickman; Adam J Ciarleglio; Ana H Kim; José A Luchsinger; Bret R Rutherford Journal: Am J Geriatr Psychiatry Date: 2020-01-21 Impact factor: 4.105
Authors: Justin S Golub; Rahul K Sharma; Brady Q Rippon; Adam M Brickman; José A Luchsinger Journal: Laryngoscope Date: 2020-07-09 Impact factor: 3.325
Authors: Matthew R Trendowski; Jessica L Baedke; Yadav Sapkota; Lois B Travis; Xindi Zhang; Omar El Charif; Heather E Wheeler; Wendy M Leisenring; Leslie L Robison; Melissa M Hudson; Lindsay M Morton; Kevin C Oeffinger; Rebecca M Howell; Gregory T Armstrong; Smita Bhatia; M Eileen Dolan Journal: Cancer Date: 2021-07-19 Impact factor: 6.860
Authors: Mia Salans; Michelle D Tibbs; Minh-Phuong Huynh-Le; Anthony Yip; Kathryn Tringale; Roshan Karunamuni; Ronghui Xu; Anny Reyes; Anna Christina Macari; Tonya Pan-Weisz; Carrie R McDonald; Jona A Hattangadi-Gluth Journal: Int J Radiat Oncol Biol Phys Date: 2021-06-06 Impact factor: 7.038
Authors: Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam Journal: Lancet Date: 2020-07-30 Impact factor: 79.321